TheraRadar

Pharma Intelligence, Simplified

Landscape Oncology

ALL

1,934 clinical trials

1018 active
/
1934 total (since 2015)
388
Phase 1 Active
719 total
613
Phase 2 Active
1072 total
150
Phase 3 Active
292 total
51
Phase 4 Active
159 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Novartis 7 3 9
AstraZeneca 6 4 0
Sichuan Baili Pharmaceutical Co., Ltd. 6 0 0
Amgen 5 6 1
Pfizer 5 3 0
Chongqing Precision Biotech Co., Ltd 4 1 0
Inmunotek S.L. 4 0 1
Regeneron 3 7 0
Autolus Limited 3 1 0
DBV Technologies 2 5 0
ALK-Abelló A/S 2 4 1
Seagen, a wholly owned subsidiary of Pfizer 2 1 1
Juventas Cell Therapy Ltd. 2 1 1
Johnson & Johnson 2 0 1
Kite, A Gilead Company 2 1 0
NCT04214262 ACTIVE NOT RECRUITING
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
National Cancer Institute (NCI) n=480
NCT06632327 RECRUITING
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology n=1,100
NCT07223190 NOT YET RECRUITING
A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia
Amgen n=560
NCT07003919 RECRUITING
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
DBV Technologies n=480
NCT04530565 RECRUITING
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
National Cancer Institute (NCI) n=348
NCT06498635 RECRUITING
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
National Cancer Institute (NCI) n=306
NCT04402788 RECRUITING
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
National Cancer Institute (NCI) n=138
NCT03914625 ACTIVE NOT RECRUITING
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
National Cancer Institute (NCI) n=6,720
NCT07388524 NOT YET RECRUITING
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
National Cancer Institute (NCI) n=336
NCT04181060 RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
National Cancer Institute (NCI) n=300
NCT07061977 RECRUITING
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
National Cancer Institute (NCI) n=336
NCT04092283 ACTIVE NOT RECRUITING
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
National Cancer Institute (NCI) n=660
NCT02595944 ACTIVE NOT RECRUITING
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
National Cancer Institute (NCI) n=903
NCT06124157 RECRUITING
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
National Cancer Institute (NCI) n=222
NCT04267848 RECRUITING
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI) n=1,210
NCT06096844 RECRUITING
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
National Cancer Institute (NCI) n=304
NCT02502266 ACTIVE NOT RECRUITING
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
National Cancer Institute (NCI) n=582
NCT02839707 ACTIVE NOT RECRUITING
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI) n=444
NCT02193282 ACTIVE NOT RECRUITING
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
National Cancer Institute (NCI) n=390
NCT02446600 ACTIVE NOT RECRUITING
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI) n=579
NCT03375320 ACTIVE NOT RECRUITING
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
National Cancer Institute (NCI) n=298
NCT07396480 RECRUITING
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
First Affiliated Hospital of Zhejiang University n=186
NCT07309562 RECRUITING
The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age
Xiamen Amoytop Biotech Co., Ltd. n=141
NCT06868277 RECRUITING
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
AstraZeneca n=830
NCT04423211 RECRUITING
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ECOG-ACRIN Cancer Research Group n=804
NCT07441291 RECRUITING
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Peking University People's Hospital n=70
NCT07440290 NOT YET RECRUITING
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
Cancer Research UK n=30
NCT03774732 ACTIVE NOT RECRUITING
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
UNICANCER n=327
NCT04428905 ACTIVE NOT RECRUITING
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer
City of Hope Medical Center n=403
NCT03844048 ACTIVE NOT RECRUITING
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
AbbVie n=165
NCT05602194 RECRUITING
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Children's Oncology Group n=440
NCT03959085 RECRUITING
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Children's Oncology Group n=5,951
NCT03007147 ACTIVE NOT RECRUITING
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Children's Oncology Group n=475
NCT03394365 RECRUITING
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Pierre Fabre Medicament n=115
NCT06819592 RECRUITING
PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury
The George Institute n=3,300
NCT07417735 NOT YET RECRUITING
SYS6010 Versus Chemotherapy in Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. n=436
NCT06976775 RECRUITING
Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study
Pablo Rodríguez del Rio n=40
NCT06596577 ENROLLING BY INVITATION
Nudging Effective and Equitable Delivery of Specialty Palliative Care
University of Pennsylvania n=18,000
NCT04094311 RECRUITING
Study of Out of Specification for Tisagenlecleucel
Novartis Pharmaceuticals n=200
NCT07223021 RECRUITING
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center n=130
NCT07118527 RECRUITING
A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. n=600
NCT04994717 RECRUITING
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
Amgen n=304
NCT06860269 RECRUITING
A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia
Assistance Publique - Hôpitaux de Paris n=1,200
NCT07309432 RECRUITING
Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Regeneron Pharmaceuticals n=350
NCT06351020 ACTIVE NOT RECRUITING
LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.
LaNova Medicines Zhejiang Co., Ltd. n=387
NCT04810091 ACTIVE NOT RECRUITING
Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor
M.D. Anderson Cancer Center n=79
NCT05867472 RECRUITING
Advancing Brain Outcomes in Pediatric Critically Ill Patients Sedated With Volatile AnEsthestic Agents
Sunnybrook Health Sciences Centre n=60
NCT04877288 RECRUITING
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
Bristol-Myers Squibb n=102
NCT06387290 RECRUITING
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
University of Utah n=300
NCT07366801 RECRUITING
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Federal Research Institute of Pediatric Hematology, Oncology and Immunology n=64
NCT06616584 RECRUITING
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
SWOG Cancer Research Network n=378
NCT07361484 NOT YET RECRUITING
Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)
BeyondSpring Pharmaceuticals Inc. n=442
NCT07362186 NOT YET RECRUITING
LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
LaNova Medicines Limited n=400
NCT03020030 ACTIVE NOT RECRUITING
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Dana-Farber Cancer Institute n=560
NCT05741476 ACTIVE NOT RECRUITING
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
DBV Technologies n=600
NCT06723392 RECRUITING
Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries
NICHD Global Network for Women's and Children's Health n=1,134
NCT06205316 RECRUITING
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Mayo Clinic n=118
NCT06500481 RECRUITING
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
NRG Oncology n=115
NCT06500455 RECRUITING
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
NRG Oncology n=269
NCT05624996 RECRUITING
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
NRG Oncology n=474
NCT04095364 ACTIVE NOT RECRUITING
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NRG Oncology n=450
NCT04804644 RECRUITING
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
NRG Oncology n=200
NCT06580314 RECRUITING
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
NRG Oncology n=880
NCT06908304 RECRUITING
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Maia Biotechnology n=300
NCT05327894 RECRUITING
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Princess Maxima Center for Pediatric Oncology n=160
NCT07221851 RECRUITING
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S n=186
NCT03602859 ACTIVE NOT RECRUITING
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Tesaro, Inc. n=1,400
NCT07072585 NOT YET RECRUITING
Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)
Children's Oncology Group n=1,708
NCT07060885 RECRUITING
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
ALK-Abelló A/S n=300
NCT06699108 ACTIVE NOT RECRUITING
Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy
Shanghai Vitalgen BioPharma Co., Ltd. n=45
NCT07297914 NOT YET RECRUITING
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Bambino Gesù Hospital and Research Institute n=1,000
NCT05457556 ACTIVE NOT RECRUITING
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
Children's Oncology Group n=435
NCT03391869 ACTIVE NOT RECRUITING
Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
M.D. Anderson Cancer Center n=339
NCT07144280 RECRUITING
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Pfizer n=680
NCT07277842 NOT YET RECRUITING
PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer
Sun Yat-sen University n=382
NCT03117751 ACTIVE NOT RECRUITING
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
St. Jude Children's Research Hospital n=790
NCT03811002 ACTIVE NOT RECRUITING
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
National Cancer Institute (NCI) n=544
NCT07252544 NOT YET RECRUITING
Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)
Beijing Tiantan Hospital n=3,156
NCT03589326 ACTIVE NOT RECRUITING
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
Takeda n=245
NCT03793179 ACTIVE NOT RECRUITING
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
National Cancer Institute (NCI) n=600
NCT05535738 RECRUITING
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Wei-Che Ko n=45
NCT05206955 RECRUITING
Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology
Mayo Clinic n=80
NCT03637816 ACTIVE NOT RECRUITING
Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer
M.D. Anderson Cancer Center n=25
NCT04695925 ACTIVE NOT RECRUITING
Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations
Li Zhang, MD n=294
NCT07203352 RECRUITING
Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL
Nanfang Hospital, Southern Medical University n=154
NCT06560255 RECRUITING
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
Professor Klaus Bønnelykke n=2,000
NCT06570889 RECRUITING
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Professor Klaus Bønnelykke n=2,000
NCT06674460 RECRUITING
Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease
Peking Union Medical College Hospital n=600
NCT06767358 NOT YET RECRUITING
Ketamine Sedation in the ICU (KANINE) RCT
McMaster University n=54
NCT07177443 NOT YET RECRUITING
Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology n=456
NCT02716233 ACTIVE NOT RECRUITING
A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents
Assistance Publique - Hôpitaux de Paris n=2,044
NCT04575935 RECRUITING
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
M.D. Anderson Cancer Center n=580
NCT07157514 NOT YET RECRUITING
Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
Actinium Pharmaceuticals n=306
NCT07152041 RECRUITING
Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
Institute of Hematology & Blood Diseases Hospital, China n=150
NCT06882057 RECRUITING
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Institute of Hematology & Blood Diseases Hospital, China n=3,000
NCT06855810 RECRUITING
Newly-diagnosed Pediatric T-cell ALL Protocol
Institute of Hematology & Blood Diseases Hospital, China n=610
NCT07118800 NOT YET RECRUITING
Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old
UNICANCER n=160
NCT06919614 RECRUITING
STI Testing to Enhance PrEP Use in Pregnancy
Botswana Harvard AIDS Institute Partnership n=600
NCT07059156 RECRUITING
Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL
Shanxi Bethune Hospital n=50
NCT04498117 ACTIVE NOT RECRUITING
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
CanariaBio Inc. n=615
NCT04851717 ACTIVE NOT RECRUITING
Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
Acacia Pharma Ltd n=100
NCT05943795 ACTIVE NOT RECRUITING
A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. n=589
NCT07013123 NOT YET RECRUITING
Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab
University Hospital, Montpellier n=38
NCT05633602 ACTIVE NOT RECRUITING
Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
SWOG Cancer Research Network n=838
NCT04155034 RECRUITING
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
SWOG Cancer Research Network n=668
NCT05482516 RECRUITING
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Georgetown University n=20
NCT05096663 ACTIVE NOT RECRUITING
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
SWOG Cancer Research Network n=82
NCT04898283 RECRUITING
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Inmunotek S.L. n=180
NCT04435990 RECRUITING
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Inmunotek S.L. n=150
NCT04891237 RECRUITING
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Inmunotek S.L. n=180
NCT06303128 RECRUITING
Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
James Tarbox, MD n=380
NCT04516369 ACTIVE NOT RECRUITING
Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy
Novartis Pharmaceuticals n=4
NCT06712420 RECRUITING
Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
Rajiv Gandhi Cancer Institute & Research Center, India n=114
NCT06431633 RECRUITING
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
Fundación GECP n=129
NCT06920771 ACTIVE NOT RECRUITING
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
HAL Allergy n=552
NCT05593458 RECRUITING
Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1
Zhejiang University n=190
NCT03643276 RECRUITING
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Martin Schrappe n=5,000
NCT05766904 ACTIVE NOT RECRUITING
Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections
Chinese University of Hong Kong n=150
NCT04770012 RECRUITING
AERIAL Trial: Antiplatelet Therapy in Heart Transplantation
Ottawa Heart Institute Research Corporation n=135
NCT04924868 RECRUITING
Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis
Hospital General Universitario de Alicante n=332
NCT06258811 RECRUITING
Neoadjuvant Immunochemotherapy for LAOSCC
Lai-ping Zhong n=134
NCT04314219 RECRUITING
Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
King Faisal Specialist Hospital & Research Center n=264
NCT06361329 RECRUITING
Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
First Affiliated Hospital of Zhejiang University n=81
NCT05737303 RECRUITING
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
Women's Hospital School Of Medicine Zhejiang University n=538
NCT05674539 ENROLLING BY INVITATION
Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology n=200
NCT06764238 RECRUITING
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
Institute of Hematology & Blood Diseases Hospital, China n=1,800
NCT06771791 RECRUITING
Evaluation of the Efficacy of Oral Immunotherapy with Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospective, Multicenter, Comparative Phase III Study
University Hospital, Strasbourg, France n=110
NCT04722848 ACTIVE NOT RECRUITING
Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL
Gruppo Italiano Malattie EMatologiche dell'Adulto n=236
NCT05261399 RECRUITING
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
AstraZeneca n=324
NCT06743646 RECRUITING
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
Chigenovo Co., Ltd n=62
NCT06756152 RECRUITING
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
Federal Research Institute of Pediatric Hematology, Oncology and Immunology n=50
NCT06705062 ACTIVE NOT RECRUITING
Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination with Post-engraftment Anti-thymoglobin As Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation
Shanghai Jiao Tong University School of Medicine n=316
NCT06051409 RECRUITING
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ALL.
Ascentage Pharma Group Inc. n=350
NCT06673459 NOT YET RECRUITING
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
The First Affiliated Hospital of Soochow University n=430
NCT06672133 NOT YET RECRUITING
Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC
Jinming Yu n=524
NCT05566041 ACTIVE NOT RECRUITING
A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer
EpicentRx, Inc. n=292
NCT06275958 RECRUITING
DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer
Leiden University Medical Center n=587
NCT06577077 NOT YET RECRUITING
Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis
Ache Laboratorios Farmaceuticos S.A. n=432
NCT06475820 ACTIVE NOT RECRUITING
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis
Federal Research Institute of Pediatric Hematology, Oncology and Immunology n=150
NCT06561763 NOT YET RECRUITING
TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University n=416
NCT05395689 RECRUITING
Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM
Probelte Pharma S.L.U. n=350
NCT05029531 RECRUITING
Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology n=80
NCT06182319 RECRUITING
Optimizing Treatment of Adhesive Small Bowel Obstruction
University of California, Los Angeles n=40
NCT06177041 RECRUITING
M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.
FutureGen Biopharmaceutical (Beijing) Co., Ltd n=486
NCT05641272 NOT YET RECRUITING
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
Inmunotek S.L. n=90
NCT05515029 ACTIVE NOT RECRUITING
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis
Federal Research Institute of Pediatric Hematology, Oncology and Immunology n=56
NCT05897034 NOT YET RECRUITING
Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men
Tanta University n=100
NCT05860868 RECRUITING
Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital, Sun Yat-Sen University n=474
NCT03667651 ACTIVE NOT RECRUITING
The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants
University of Melbourne n=760
NCT05062005 RECRUITING
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital, Sun Yat-Sen University n=447
NCT04929041 SUSPENDED
Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative
National Cancer Institute (NCI) n=427
NCT06732401 SUSPENDED
Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
National Cancer Institute (NCI) n=630
NCT03150693 SUSPENDED
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Alliance for Clinical Trials in Oncology n=310
NCT03976323 COMPLETED
Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
Merck Sharp & Dohme LLC n=1,003
NCT02730299 COMPLETED
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
Gamida Cell ltd n=125
NCT03976362 COMPLETED
A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)
Merck Sharp & Dohme LLC n=851
NCT03088540 COMPLETED
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Regeneron Pharmaceuticals n=712
NCT04801823 COMPLETED
The TreEat Study- Can Early Introduction of Tree Nuts Prevent Tree Nut Allergy in Infants With Peanut Allergy
Murdoch Childrens Research Institute n=212
NCT04817761 TERMINATED
SPARK-ALL: Calaspargase Pegol in Adults With ALL
Institut de Recherches Internationales Servier n=42
NCT05149365 COMPLETED
Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation
The First Affiliated Hospital of Soochow University n=190
NCT03656926 COMPLETED
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
Zambon SpA n=169
NCT05579327 COMPLETED
Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)
Rare Thyroid Therapeutics International AB n=20
NCT07378410 COMPLETED
Role of Intra-Operative Aspiration in Distended GB in LC
Aswan University n=70
NCT03456063 COMPLETED
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
Hoffmann-La Roche n=453
NCT05678959 TERMINATED
Long-term Extension Study of Ligelizumab in Food Allergy
Novartis Pharmaceuticals n=163
NCT03768414 COMPLETED
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
SWOG Cancer Research Network n=452
NCT04244877 WITHDRAWN
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
MetroHealth Medical Center
NCT04684524 COMPLETED
Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)
Sanofi n=62
NCT02881086 COMPLETED
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
Goethe University n=1,023
NCT05668390 COMPLETED
Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma
Stallergenes Greer n=553
NCT03657342 COMPLETED
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
Zambon SpA n=62
NCT03881696 COMPLETED
Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants
National Institute of Allergy and Infectious Diseases (NIAID) n=471
NCT06602726 COMPLETED
A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy
Regeneron Pharmaceuticals n=64
NCT06602739 COMPLETED
A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy
Regeneron Pharmaceuticals n=54
NCT07125508 COMPLETED
Tranexamic Acid for The Management of Bleeding Gastrointestinal Angioectasias
Louisiana State University Health Sciences Center in New Orleans n=40
NCT05191186 COMPLETED
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
Aarhus University Hospital n=450
NCT05815758 COMPLETED
Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution
Bausch & Lomb Incorporated n=512
NCT05591755 COMPLETED
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
Bausch & Lomb Incorporated n=229
NCT05408910 WITHDRAWN
Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis
Wake Forest University Health Sciences
NCT05157841 COMPLETED
Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy
Pacira Pharmaceuticals, Inc n=185
NCT02636699 COMPLETED
Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
DBV Technologies n=500
NCT04588246 TERMINATED
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
NRG Oncology n=19
NCT03859700 COMPLETED
Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children
DBV Technologies n=304
NCT05498467 COMPLETED
The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis
Herlev and Gentofte Hospital n=20
NCT03231358 COMPLETED
Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South Africa
Brown University n=1,758
NCT05545072 TERMINATED
Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)
Emory University n=5
NCT04984876 TERMINATED
Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy
Novartis Pharmaceuticals n=211
NCT06880965 COMPLETED
Effect of Concentrated Growth Factors on Short Implant-Supported Overdentures
Tanta University n=10
NCT05579730 COMPLETED
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
Bausch & Lomb Incorporated n=188
NCT03494504 COMPLETED
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Aldeyra Therapeutics, Inc. n=318
NCT04878354 COMPLETED
A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis
ALK-Abelló A/S n=952
NCT02523222 COMPLETED
Dextrose Gel Does Not Prevent Neonatal Hypoglycemia
Baylor College of Medicine n=236
NCT04971109 COMPLETED
Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days
SIGA Technologies n=467
NCT03292484 COMPLETED
Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Aimmune Therapeutics, Inc. n=911
NCT03211247 COMPLETED
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age
DBV Technologies n=414
NCT04881461 COMPLETED
A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis
ALK-Abelló A/S n=445
NCT04207736 COMPLETED
The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.
Aldeyra Therapeutics, Inc. n=95
NCT03451591 COMPLETED
LACunar Intervention (LACI-2) Trial-2
University of Edinburgh n=363
NCT03673072 COMPLETED
Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC
Krankenhaus Nordwest n=68
NCT04103814 TERMINATED
Effect of Topical CBD Cream for Degenerative Hallux Disorders
Rush University Medical Center n=11
NCT05369234 COMPLETED
Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis
Covenant Health Cancer Center n=100
NCT03374800 COMPLETED
Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial
McMaster University n=4,800
NCT04776083 COMPLETED
Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients
Menoufia University n=75
NCT03275636 COMPLETED
Haploidentical Donor vs mMUD in Hematological Malignancies
DKMS gemeinnützige GmbH n=98
NCT06461949 WITHDRAWN
Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
National Institute on Deafness and Other Communication Disorders (NIDCD)
NCT04642469 COMPLETED
Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.
AstraZeneca n=30
NCT06179732 COMPLETED
Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities
The Mentor Initiative n=2,400
NCT05612984 WITHDRAWN
Calcium Aspirin Multiple Micronutrients (CAMMS) to Reduce Preterm Birth
Johns Hopkins Bloomberg School of Public Health
NCT05234554 COMPLETED
The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis
Aldeyra Therapeutics, Inc. n=131
NCT03699956 TERMINATED
RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer
EpicentRx, Inc. n=18
NCT02470780 COMPLETED
Treating Bacterial Overgrowth in Parkinson's Disease
University of Cincinnati n=4
NCT03764293 COMPLETED
A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC
Jiangsu HengRui Medicine Co., Ltd. n=543
NCT04553068 COMPLETED
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
Evofem Inc. n=1,892
NCT06212973 COMPLETED
A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. n=266
NCT04874714 TERMINATED
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
Inmunotek S.L. n=18
NCT03133377 COMPLETED
Treatment of Invasively Ventilated Adults With Early Activity and Mobilisation
Australian and New Zealand Intensive Care Research Centre n=750
NCT04145531 COMPLETED
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
Jazz Pharmaceuticals n=229
NCT03734211 COMPLETED
Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients
Lars Gullestad n=130
NCT03573921 TERMINATED
Gastrografin for Treating Small Bowel Obstruction in Children
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's n=2
NCT05579964 COMPLETED
The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot
National Cardiovascular Center Harapan Kita Hospital Indonesia n=66
NCT03626545 TERMINATED
Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy
Novartis Pharmaceuticals n=245
NCT04541004 COMPLETED
Adolescent Mite Allergy Safety Evaluation
ALK-Abelló A/S n=253
NCT03489941 COMPLETED
A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle
Bausch & Lomb Incorporated n=65
NCT03524937 COMPLETED
Prevention of Delirium in Intensive Care by Melatonin
Assistance Publique - Hôpitaux de Paris n=355
NCT05846243 COMPLETED
Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" n=334
NCT04291456 TERMINATED
Minocycline in MS: Confirmation of Benefit
University of Calgary n=9
NCT04810390 COMPLETED
Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children
Faes Farma, S.A. n=59
NCT03479307 COMPLETED
A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.
Faes Farma, S.A. n=228
NCT05065164 WITHDRAWN
Denosumab and Screw Fixation for Osteoporotic Compression Fracture
Shenzhen People's Hospital
NCT03082014 TERMINATED
Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function
Ludwig-Maximilians - University of Munich n=101
NCT03736447 COMPLETED
Peanut Oral Immunotherapy Study of Early Intervention for Desensitization
Aimmune Therapeutics, Inc. n=146
NCT04095858 TERMINATED
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) n=11
NCT03476239 COMPLETED
Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Amgen n=121
NCT05245981 COMPLETED
Clinical Application of Mg Based Biodegradable Material for Fracture Fixation in the Adult Skeleton
Medical University of Graz n=20
NCT02288377 TERMINATED
A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)
Federation Francophone de Cancerologie Digestive n=53
NCT04775329 TERMINATED
Primary Prophylaxis for Spontaneous Bacterial Peritonitis
Changi General Hospital n=2
NCT02201381 WITHDRAWN
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer
Health Clinics Limited
NCT04176185 TERMINATED
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber
ALK-Abelló A/S n=80
NCT02975479 COMPLETED
Intralymphatic Immunotherapy in Increasing Doses, Substudy
Karolinska Institutet n=40
NCT02625610 COMPLETED
Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
EMD Serono Research & Development Institute, Inc. n=499
NCT02999854 TERMINATED
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
Kiadis Pharma n=63
NCT03317015 COMPLETED
A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)
Sanofi n=260
NCT02670252 COMPLETED
BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT
Nanfang Hospital, Southern Medical University n=550
NCT03153150 COMPLETED
Start or STop Anticoagulants Randomised Trial (SoSTART)
University of Edinburgh n=203
NCT02635776 COMPLETED
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
Aimmune Therapeutics, Inc. n=555
NCT02993107 COMPLETED
PALISADE Follow-on Study (ARC004)
Aimmune Therapeutics, Inc. n=388
NCT02369653 COMPLETED
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Bristol-Myers Squibb n=512
NCT02744742 COMPLETED
G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT
Nanfang Hospital, Southern Medical University n=202
NCT04687059 COMPLETED
An Exploratory Study of PQ Grass 27600 SU
Allergy Therapeutics n=119
NCT02848716 WITHDRAWN
Pretherapeutic Paraaortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Versus Definitive Chemoradiotherapy
Muriel POUBLANC
NCT03337542 COMPLETED
AR101 Real-World Open-Label Extension Study
Aimmune Therapeutics, Inc. n=243
NCT03126227 COMPLETED
Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES)
Aimmune Therapeutics, Inc. n=506
NCT04050865 COMPLETED
A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis
Ocular Therapeutix, Inc. n=96
NCT02367781 COMPLETED
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche n=723
NCT03201003 COMPLETED
ARTEMIS Peanut Allergy In Children
Aimmune Therapeutics, Inc. n=175
NCT03123939 COMPLETED
Phase III B in Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals n=69
NCT03703791 TERMINATED
Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents
Aimmune Therapeutics, Inc. n=1
NCT03699124 COMPLETED
Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial
Bavarian Nordic n=1,129
NCT03066466 WITHDRAWN
Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT
Loyola University
NCT03785067 TERMINATED
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study
The George Institute n=1
NCT02475850 COMPLETED
Strategies to Reduce Injuries and Develop Confidence in Elders
Brigham and Women's Hospital n=5,451
NCT02916446 COMPLETED
Safety Study of Viaskin Peanut to Treat Peanut Allergy
DBV Technologies n=393
NCT02625623 COMPLETED
Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)
EMD Serono Research & Development Institute, Inc. n=371
NCT02988882 COMPLETED
OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
Ocular Therapeutix, Inc. n=86
NCT03755557 COMPLETED
Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray
Marinomed Biotech AG n=82
NCT03628053 WITHDRAWN
Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
NCT03342300 WITHDRAWN
Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
Peking University People's Hospital
NCT04065165 WITHDRAWN
Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome
European Organisation for Research and Treatment of Cancer - EORTC
NCT03529084 WITHDRAWN
Phase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations
Novartis Pharmaceuticals
NCT04139915 WITHDRAWN
Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
Restorbio Inc.
NCT03343392 COMPLETED
The Effect of Different Drugs in the Prevention of Tooth Sensitivity Caused by Tooth Bleaching Treatment.
Universidade Estadual de Ponta Grossa n=114
NCT02770157 COMPLETED
Efficacy and Safety of DA-3002 in Short Children Borns SGA.
Dong-A ST Co., Ltd. n=75
NCT02443805 COMPLETED
Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR
Stallergenes Greer n=1,607
NCT02988778 WITHDRAWN
Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis
Eurofarma Laboratorios S.A.
NCT02972866 WITHDRAWN
Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis
Eurofarma Laboratorios S.A.
NCT02478398 COMPLETED
Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
Merck Sharp & Dohme LLC n=1,025
NCT02679105 COMPLETED
Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy
Karolinska Institutet n=38
NCT02575092 COMPLETED
The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
Fuling Central Hospital of Chongqing City n=4,000
NCT02775006 TERMINATED
Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell Carcinoma
The Netherlands Cancer Institute n=45
NCT02487225 COMPLETED
Pentoxifylline Treatment in Acute Pancreatitis (AP)
Mayo Clinic n=83
NCT02766140 TERMINATED
SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. n=12
NCT03133299 COMPLETED
A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma
Post Graduate Institute of Medical Education and Research, Chandigarh n=30
NCT02711163 COMPLETED
Evaluation of the Hypoallergenicity of an Extensively Hydrolyzed Formula
United Pharmaceuticals n=30
NCT02445326 COMPLETED
OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
Ocular Therapeutix, Inc. n=73
NCT02596321 COMPLETED
A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma
Abbott n=112
NCT02474589 COMPLETED
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
SIGA Technologies n=449
NCT03318614 COMPLETED
Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster
Universiti Sains Malaysia n=53
NCT02920684 COMPLETED
Haemodynamic and Metabolism Response During Early Rehabilitation in Sedated Patients
University Hospital, Rouen n=20
NCT02498509 COMPLETED
Clinical Trial to Evaluate the Efficacy and Safety of CKD-342
Chong Kun Dang Pharmaceutical n=459
NCT02634385 WITHDRAWN
Zero Ischemia Laparoscopic Partial Nephrectomy
St. Joseph's Healthcare Hamilton
NCT02492321 COMPLETED
A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis
Eleven Biotherapeutics n=250
NCT02401191 COMPLETED
A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis
Sanofi n=105